中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Personalis, Inc. (PSNL) Annual Reports

Personalis, Inc. is listed on Nasdaq, classified by the SEC under Services-Medical Laboratories (SIC 8071). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

  • Exchange: Nasdaq
  • Fiscal year end: 12/31
  • SEC CIK: 1527753 →

Website:Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
CurrentPrior yearYoY
Revenue $22.4M $17.2M +30.0%
Operating income $-33.6M $-21.8M -54.1%
Net income $-31.7M $-20.1M -58.0%
EPS (diluted) $-0.30 $-0.23 -30.4%
Company guidance
PeriodRange
Revenue FY2026 $78M – $80M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit
Quarterly · In mn (USD)
Revenue 22.4 mn Net income -31.7 mn
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2
Show table:Income statement
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Revenue9.39 4.16 8.80 11.7 13.2 14.1 15.8 17.1 18.1 19.2 19.5 19.8 20.2 20.9 21.7 22.3 20.7 15.2 18.2 14.9 16.7 18.9 16.7 18.3 19.7 19.5 22.6 25.7 16.8 20.6 17.2 14.5 17.4 15.5 22.4
Gross profit0.1 2.40 4.48 4.83 3.98 5.90 5.63 6.57
Operating income-22.2 -3.71 -1.75 -3.15 -5.43 -4.06 -5.73 -7.20 -9.62 -9.50 -9.65 -13.4 -12.5 -14.9 -17.7 -20.2 -28.3 -27.9 -27.3 -32.1 -29.8 -25.4 -30.8 -24.0 -18.9 -16.9 -14.4 -18.1 -17.7 -21.8 -23.3 -25.3 -32.2 -33.6
Net income-23.6 -5.37 -7.31 -3.64 -3.55 -5.68 -5.87 -6.88 -6.64 -9.14 -9.26 -9.54 -13.3 -12.4 -14.9 -17.7 -20.2 -28.2 -27.6 -26.5 -31.1 -28.7 -23.9 -29.1 -26.6 -13.0 -12.8 -39.1 -16.4 -15.8 -20.1 -21.6 -23.8 -30.0 -31.7
Balance sheet
Quarterly · In mn (USD)
Total assets 312 mn Total liabilities 77.0 mn
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table:Balance sheet
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Current assets29.6 176 140 140 135 120 224 221 373 354 329 318 294 260 222 200 183 161 148 147 120 113 170 203 206 193 174 268 258 245
Total assets41.7 192 160 157 152 146 249 245 396 383 407 397 381 358 318 293 272 249 227 225 195 186 240 270 273 259 243 334 325 312
Current liabilities57.9 56.3 47.4 50.0 52.1 43.0 35.9 40.6 38.6 34.1 26.5 31.3 39.8 41.5 33.7 33.1 34.1 28.6 32.5 47.2 31.4 34.1 36.4 31.1 29.9 31.7 36.2 39.6 39.0 46.4
Total liabilities58.6 74.8 48.3 50.6 52.7 52.4 45.3 49.9 47.1 44.6 81.4 86.2 93.9 93.3 75.5 74.6 78.5 73.0 75.4 95.7 74.6 73.2 73.1 67.3 66.0 67.8 71.4 73.0 70.6 77.0
Equity-92.6 -101 -103 -106 -111 117 111 107 99.2 93.1 204 195 348 339 325 310 287 265 242 218 194 176 151 129 121 112 167 203 207 191 171 261 255 235
Cash flow
Quarterly · In mn (USD)
Operating -25.8 mn Investing 38.2 mn Financing 7.99 mn
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Positive = cash in, negative = cash out.

Show table:Cash flow statement
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Operating0.29 2.80 -0.43 3.20 0.07 -10.9 -9.64 2.40 -8.64 -15.3 -16.1 -2.53 -11.7 -25.9 -17.9 -15.3 -11.4 -27.4 -14.8 -16.8 -15.7 -10.4 -16.7 -13.4 -20.4 -10.7 -6.20 -7.80 -18.0 -12.9 -21.8 -22.3 -22.5 -25.8
Investing-5.16 -5.24 -1.94 -0.67 -0.96 -1.84 -43.9 -34.9 -0.04 -7.61 5.65 -63.1 -82.5 -47.1 29.7 39.9 -3.16 23.0 10.8 21.9 13.8 19.6 -8.60 -11.6 6.30 13.0 -28.2 -26.2 -22.5 -4.37 18.7 -14.4 -46.0 38.2
Financing16.4 -0.4 -0.23 0.04 14.4 143 -22.7 0.47 0.32 1.32 119 0.94 163 6.01 -0.51 1.35 0.52 -0.42 0.76 0.51 0.93 0.29 9.82 1.13 1.52 62.4 49.6 20.1 -0.33 -0.32 111 17.8 7.99
Cash at period end22.6 19.8 19.7 163 87.0 55.0 46.7 25.0 133 68.5 137 70.1 79.6 106 91.6 86.7 83.5 89.1 87.2 97.2 72.2 57.0 44.0 47.8 75.8 91.4 71.0 53.4 50.0 124 73.6 94.0
Profitability
Quarterly · %
Gross margin 36.2% Operating margin -150.3% Net margin -141.7%
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

Gross, operating and net margin = the respective profit ÷ revenue.

Show table:Profitability
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
Gross margin2.4%27.2%38.5%36.7%28.3%37.3%32.8%36.2%
Operating margin-235.9%-42.1%-15.0%-23.9%-38.6%-25.7%-33.4%-39.6%-50.2%-48.7%-48.7%-66.3%-59.8%-69.0%-79.5%-97.8%-185.9%-152.9%-183.5%-191.9%-158.1%-151.8%-168.8%-121.8%-96.7%-74.8%-55.9%-107.8%-85.9%-126.8%-160.7%-145.7%-207.9%-150.3%
Net margin-251.2%-129.1%-83.1%-31.2%-27.0%-40.4%-37.1%-40.1%-36.6%-47.7%-47.5%-48.2%-66.1%-59.4%-69.0%-79.4%-97.7%-185.3%-151.0%-178.3%-185.8%-152.0%-143.4%-159.5%-135.1%-66.4%-56.7%-152.0%-97.8%-76.4%-116.6%-149.4%-137.3%-194.1%-141.7%
Returns & leverage
Quarterly · %
ROE -50.3% ROA -37.5% Debt ratio 24.7%
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table:Returns & leverage
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
ROE-231.2%-542.7%-16611.9%-30.4%-22.0%-27.4%-19.9%-23.3%-22.1%-25.8%-25.5%-31.0%-36.1%-42.9%-47.4%-50.0%-57.3%-62.3%-58.9%-56.5%-57.5%-48.9%-51.3%-60.3%-43.7%-35.0%-41.4%-50.3%
ROA-47.7%-9.8%-13.8%-25.2%-18.8%-18.9%-16.9%-20.5%-16.3%-19.0%-17.8%-20.3%-20.9%-25.3%-28.3%-32.9%-34.9%-36.3%-41.4%-41.8%-39.6%-37.5%-39.2%-32.8%-35.9%-41.1%-30.6%-26.9%-31.9%-37.5%
Debt ratio140.8%39.0%30.3%32.2%34.7%36.0%18.2%20.4%11.9%11.6%20.0%21.8%24.7%26.1%23.7%25.5%28.9%29.3%33.3%42.5%38.2%39.5%30.5%24.9%24.1%26.2%29.4%21.8%21.7%24.7%
EPS
Quarterly · US$
EPS US$-0.30
2017Q4 2018Q1 2018Q2 2018Q3 2018Q4 2019Q1 2019Q2 2019Q3 2019Q4 2020Q1 2020Q2 2020Q3 2020Q4 2021Q1 2021Q2 2021Q3 2021Q4 2022Q1 2022Q2 2022Q3 2022Q4 2023Q1 2023Q2 2023Q3 2023Q4 2024Q1 2024Q2 2024Q3 2024Q4 2025Q1 2025Q2 2025Q3 2025Q4 2026Q1 2026Q2
Show table:EPS
Item2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q32024Q42025Q12025Q22025Q32025Q42026Q12026Q2
EPS(US$)-1.20-0.34-0.40-0.46-0.63-0.60-0.58-0.67-0.61-0.50-0.60-0.54-0.26-0.24-0.64-0.18-0.18-0.23-0.24-0.26-0.29-0.30

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Personalis, Inc. (PSNL) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.